Jump to ContentJump to Main Navigation
Contraceptive RiskThe FDA, Depo-Provera, and the Politics of Experimental Medicine$
Users without a subscription are not able to see the full content.

William Green

Print publication date: 2017

Print ISBN-13: 9781479876990

Published to NYU Press Scholarship Online: January 2018

DOI: 10.18574/nyu/9781479876990.001.0001

Show Summary Details
Page of

PRINTED FROM NYU Press SCHOLARSHIP ONLINE (www.nyu.universitypressscholarship.com). (c) Copyright University of NYU Press Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in NYSO for personal use.date: 25 February 2021



Contraceptive Drug Risk Failure, Human Dignity, and a Duty to Act

(p.213) Conclusion
Contraceptive Risk

William Green

NYU Press

The odyssey of Depo-Provera has been told as three stories of the politics of contraceptive drug risk management. The stories have joined the national struggle over Upjohn’s FDA application to have the drug licensed as a female contraceptive to the state medical malpractice and products liability issues raised by its contraceptive use and the criminal justice issues raised by its use as a probation and parole condition for sex offenders....

NYU Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.